The global Equine Pharmaceuticals and Supplements market size was valued at USD 1181.2 million in 2022 and is forecast to a readjusted size of USD 1586.8 million by 2029 with a CAGR of 4.3% during review period.
Equine Pharmaceuticals and Supplements are medicines or supplements that are specially used to supplement nutrition and cure diseases.
Global Equine Pharmaceuticals and Supplements key players include Boehringer Ingelheim, Merck Animal Health, Zoetis, etc. Global top three manufacturers hold a share over 50%. North America is the largest market, with a share over 45%, followed by Europe, and Asia-Pacific, both have a share over 30 percent. In terms of product, Pharmaceuticals is the largest segment, with a share about 80%. And in terms of application, the largest application is Thoroughbred Horse, etc.
This report is a detailed and comprehensive analysis for global Equine Pharmaceuticals and Supplements market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Equine Pharmaceuticals and Supplements market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2018-2029
Global Equine Pharmaceuticals and Supplements market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2018-2029
Global Equine Pharmaceuticals and Supplements market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2018-2029
Global Equine Pharmaceuticals and Supplements market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (USD/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Equine Pharmaceuticals and Supplements
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Equine Pharmaceuticals and Supplements market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Boehringer Ingelheim
Merck Animal Health
Zoetis
Bayer Animal Health
Elanco Animal Health
Dechra Veterinary Products
CEVA
Virbac
Norbrook Equine
Kyoritsu Seiyaku
Vetoquinol
Protexin Healthcare
Audevard
Ouro Fino Saude
Pharmaceuticals
Supplements
Thoroughbred Horse
Other Types of Horses
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Chapter 1, to describe Equine Pharmaceuticals and Supplements product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Equine Pharmaceuticals and Supplements, with price, sales, revenue and global market share of Equine Pharmaceuticals and Supplements from 2018 to 2023.
Chapter 3, the Equine Pharmaceuticals and Supplements competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Equine Pharmaceuticals and Supplements breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Equine Pharmaceuticals and Supplements market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Equine Pharmaceuticals and Supplements.
Chapter 14 and 15, to describe Equine Pharmaceuticals and Supplements sales channel, distributors, customers, research findings and conclusion.
1 Market Overview
1.1 Product Overview and Scope of Equine Pharmaceuticals and Supplements
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Equine Pharmaceuticals and Supplements Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Pharmaceuticals
1.3.3 Supplements
1.4 Market Analysis by Application
1.4.1 Overview: Global Equine Pharmaceuticals and Supplements Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Thoroughbred Horse
1.4.3 Other Types of Horses
1.5 Global Equine Pharmaceuticals and Supplements Market Size & Forecast
1.5.1 Global Equine Pharmaceuticals and Supplements Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Equine Pharmaceuticals and Supplements Sales Quantity (2018-2029)
1.5.3 Global Equine Pharmaceuticals and Supplements Average Price (2018-2029)
2 Manufacturers Profiles
2.1 Boehringer Ingelheim
2.1.1 Boehringer Ingelheim Details
2.1.2 Boehringer Ingelheim Major Business
2.1.3 Boehringer Ingelheim Equine Pharmaceuticals and Supplements Product and Services
2.1.4 Boehringer Ingelheim Equine Pharmaceuticals and Supplements Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Boehringer Ingelheim Recent Developments/Updates
2.2 Merck Animal Health
2.2.1 Merck Animal Health Details
2.2.2 Merck Animal Health Major Business
2.2.3 Merck Animal Health Equine Pharmaceuticals and Supplements Product and Services
2.2.4 Merck Animal Health Equine Pharmaceuticals and Supplements Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Merck Animal Health Recent Developments/Updates
2.3 Zoetis
2.3.1 Zoetis Details
2.3.2 Zoetis Major Business
2.3.3 Zoetis Equine Pharmaceuticals and Supplements Product and Services
2.3.4 Zoetis Equine Pharmaceuticals and Supplements Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Zoetis Recent Developments/Updates
2.4 Bayer Animal Health
2.4.1 Bayer Animal Health Details
2.4.2 Bayer Animal Health Major Business
2.4.3 Bayer Animal Health Equine Pharmaceuticals and Supplements Product and Services
2.4.4 Bayer Animal Health Equine Pharmaceuticals and Supplements Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Bayer Animal Health Recent Developments/Updates
2.5 Elanco Animal Health
2.5.1 Elanco Animal Health Details
2.5.2 Elanco Animal Health Major Business
2.5.3 Elanco Animal Health Equine Pharmaceuticals and Supplements Product and Services
2.5.4 Elanco Animal Health Equine Pharmaceuticals and Supplements Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Elanco Animal Health Recent Developments/Updates
2.6 Dechra Veterinary Products
2.6.1 Dechra Veterinary Products Details
2.6.2 Dechra Veterinary Products Major Business
2.6.3 Dechra Veterinary Products Equine Pharmaceuticals and Supplements Product and Services
2.6.4 Dechra Veterinary Products Equine Pharmaceuticals and Supplements Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Dechra Veterinary Products Recent Developments/Updates
2.7 CEVA
2.7.1 CEVA Details
2.7.2 CEVA Major Business
2.7.3 CEVA Equine Pharmaceuticals and Supplements Product and Services
2.7.4 CEVA Equine Pharmaceuticals and Supplements Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 CEVA Recent Developments/Updates
2.8 Virbac
2.8.1 Virbac Details
2.8.2 Virbac Major Business
2.8.3 Virbac Equine Pharmaceuticals and Supplements Product and Services
2.8.4 Virbac Equine Pharmaceuticals and Supplements Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Virbac Recent Developments/Updates
2.9 Norbrook Equine
2.9.1 Norbrook Equine Details
2.9.2 Norbrook Equine Major Business
2.9.3 Norbrook Equine Equine Pharmaceuticals and Supplements Product and Services
2.9.4 Norbrook Equine Equine Pharmaceuticals and Supplements Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Norbrook Equine Recent Developments/Updates
2.10 Kyoritsu Seiyaku
2.10.1 Kyoritsu Seiyaku Details
2.10.2 Kyoritsu Seiyaku Major Business
2.10.3 Kyoritsu Seiyaku Equine Pharmaceuticals and Supplements Product and Services
2.10.4 Kyoritsu Seiyaku Equine Pharmaceuticals and Supplements Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Kyoritsu Seiyaku Recent Developments/Updates
2.11 Vetoquinol
2.11.1 Vetoquinol Details
2.11.2 Vetoquinol Major Business
2.11.3 Vetoquinol Equine Pharmaceuticals and Supplements Product and Services
2.11.4 Vetoquinol Equine Pharmaceuticals and Supplements Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Vetoquinol Recent Developments/Updates
2.12 Protexin Healthcare
2.12.1 Protexin Healthcare Details
2.12.2 Protexin Healthcare Major Business
2.12.3 Protexin Healthcare Equine Pharmaceuticals and Supplements Product and Services
2.12.4 Protexin Healthcare Equine Pharmaceuticals and Supplements Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Protexin Healthcare Recent Developments/Updates
2.13 Audevard
2.13.1 Audevard Details
2.13.2 Audevard Major Business
2.13.3 Audevard Equine Pharmaceuticals and Supplements Product and Services
2.13.4 Audevard Equine Pharmaceuticals and Supplements Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Audevard Recent Developments/Updates
2.14 Ouro Fino Saude
2.14.1 Ouro Fino Saude Details
2.14.2 Ouro Fino Saude Major Business
2.14.3 Ouro Fino Saude Equine Pharmaceuticals and Supplements Product and Services
2.14.4 Ouro Fino Saude Equine Pharmaceuticals and Supplements Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 Ouro Fino Saude Recent Developments/Updates
3 Competitive Environment: Equine Pharmaceuticals and Supplements by Manufacturer
3.1 Global Equine Pharmaceuticals and Supplements Sales Quantity by Manufacturer (2018-2023)
3.2 Global Equine Pharmaceuticals and Supplements Revenue by Manufacturer (2018-2023)
3.3 Global Equine Pharmaceuticals and Supplements Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Equine Pharmaceuticals and Supplements by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Equine Pharmaceuticals and Supplements Manufacturer Market Share in 2022
3.4.2 Top 6 Equine Pharmaceuticals and Supplements Manufacturer Market Share in 2022
3.5 Equine Pharmaceuticals and Supplements Market: Overall Company Footprint Analysis
3.5.1 Equine Pharmaceuticals and Supplements Market: Region Footprint
3.5.2 Equine Pharmaceuticals and Supplements Market: Company Product Type Footprint
3.5.3 Equine Pharmaceuticals and Supplements Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Equine Pharmaceuticals and Supplements Market Size by Region
4.1.1 Global Equine Pharmaceuticals and Supplements Sales Quantity by Region (2018-2029)
4.1.2 Global Equine Pharmaceuticals and Supplements Consumption Value by Region (2018-2029)
4.1.3 Global Equine Pharmaceuticals and Supplements Average Price by Region (2018-2029)
4.2 North America Equine Pharmaceuticals and Supplements Consumption Value (2018-2029)
4.3 Europe Equine Pharmaceuticals and Supplements Consumption Value (2018-2029)
4.4 Asia-Pacific Equine Pharmaceuticals and Supplements Consumption Value (2018-2029)
4.5 South America Equine Pharmaceuticals and Supplements Consumption Value (2018-2029)
4.6 Middle East and Africa Equine Pharmaceuticals and Supplements Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Equine Pharmaceuticals and Supplements Sales Quantity by Type (2018-2029)
5.2 Global Equine Pharmaceuticals and Supplements Consumption Value by Type (2018-2029)
5.3 Global Equine Pharmaceuticals and Supplements Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Equine Pharmaceuticals and Supplements Sales Quantity by Application (2018-2029)
6.2 Global Equine Pharmaceuticals and Supplements Consumption Value by Application (2018-2029)
6.3 Global Equine Pharmaceuticals and Supplements Average Price by Application (2018-2029)
7 North America
7.1 North America Equine Pharmaceuticals and Supplements Sales Quantity by Type (2018-2029)
7.2 North America Equine Pharmaceuticals and Supplements Sales Quantity by Application (2018-2029)
7.3 North America Equine Pharmaceuticals and Supplements Market Size by Country
7.3.1 North America Equine Pharmaceuticals and Supplements Sales Quantity by Country (2018-2029)
7.3.2 North America Equine Pharmaceuticals and Supplements Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Equine Pharmaceuticals and Supplements Sales Quantity by Type (2018-2029)
8.2 Europe Equine Pharmaceuticals and Supplements Sales Quantity by Application (2018-2029)
8.3 Europe Equine Pharmaceuticals and Supplements Market Size by Country
8.3.1 Europe Equine Pharmaceuticals and Supplements Sales Quantity by Country (2018-2029)
8.3.2 Europe Equine Pharmaceuticals and Supplements Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Equine Pharmaceuticals and Supplements Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Equine Pharmaceuticals and Supplements Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Equine Pharmaceuticals and Supplements Market Size by Region
9.3.1 Asia-Pacific Equine Pharmaceuticals and Supplements Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Equine Pharmaceuticals and Supplements Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Equine Pharmaceuticals and Supplements Sales Quantity by Type (2018-2029)
10.2 South America Equine Pharmaceuticals and Supplements Sales Quantity by Application (2018-2029)
10.3 South America Equine Pharmaceuticals and Supplements Market Size by Country
10.3.1 South America Equine Pharmaceuticals and Supplements Sales Quantity by Country (2018-2029)
10.3.2 South America Equine Pharmaceuticals and Supplements Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Equine Pharmaceuticals and Supplements Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Equine Pharmaceuticals and Supplements Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Equine Pharmaceuticals and Supplements Market Size by Country
11.3.1 Middle East & Africa Equine Pharmaceuticals and Supplements Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Equine Pharmaceuticals and Supplements Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Equine Pharmaceuticals and Supplements Market Drivers
12.2 Equine Pharmaceuticals and Supplements Market Restraints
12.3 Equine Pharmaceuticals and Supplements Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Equine Pharmaceuticals and Supplements and Key Manufacturers
13.2 Manufacturing Costs Percentage of Equine Pharmaceuticals and Supplements
13.3 Equine Pharmaceuticals and Supplements Production Process
13.4 Equine Pharmaceuticals and Supplements Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Equine Pharmaceuticals and Supplements Typical Distributors
14.3 Equine Pharmaceuticals and Supplements Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
List of Tables
Table 1. Global Equine Pharmaceuticals and Supplements Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Equine Pharmaceuticals and Supplements Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
Table 4. Boehringer Ingelheim Major Business
Table 5. Boehringer Ingelheim Equine Pharmaceuticals and Supplements Product and Services
Table 6. Boehringer Ingelheim Equine Pharmaceuticals and Supplements Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Boehringer Ingelheim Recent Developments/Updates
Table 8. Merck Animal Health Basic Information, Manufacturing Base and Competitors
Table 9. Merck Animal Health Major Business
Table 10. Merck Animal Health Equine Pharmaceuticals and Supplements Product and Services
Table 11. Merck Animal Health Equine Pharmaceuticals and Supplements Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Merck Animal Health Recent Developments/Updates
Table 13. Zoetis Basic Information, Manufacturing Base and Competitors
Table 14. Zoetis Major Business
Table 15. Zoetis Equine Pharmaceuticals and Supplements Product and Services
Table 16. Zoetis Equine Pharmaceuticals and Supplements Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Zoetis Recent Developments/Updates
Table 18. Bayer Animal Health Basic Information, Manufacturing Base and Competitors
Table 19. Bayer Animal Health Major Business
Table 20. Bayer Animal Health Equine Pharmaceuticals and Supplements Product and Services
Table 21. Bayer Animal Health Equine Pharmaceuticals and Supplements Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Bayer Animal Health Recent Developments/Updates
Table 23. Elanco Animal Health Basic Information, Manufacturing Base and Competitors
Table 24. Elanco Animal Health Major Business
Table 25. Elanco Animal Health Equine Pharmaceuticals and Supplements Product and Services
Table 26. Elanco Animal Health Equine Pharmaceuticals and Supplements Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Elanco Animal Health Recent Developments/Updates
Table 28. Dechra Veterinary Products Basic Information, Manufacturing Base and Competitors
Table 29. Dechra Veterinary Products Major Business
Table 30. Dechra Veterinary Products Equine Pharmaceuticals and Supplements Product and Services
Table 31. Dechra Veterinary Products Equine Pharmaceuticals and Supplements Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Dechra Veterinary Products Recent Developments/Updates
Table 33. CEVA Basic Information, Manufacturing Base and Competitors
Table 34. CEVA Major Business
Table 35. CEVA Equine Pharmaceuticals and Supplements Product and Services
Table 36. CEVA Equine Pharmaceuticals and Supplements Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. CEVA Recent Developments/Updates
Table 38. Virbac Basic Information, Manufacturing Base and Competitors
Table 39. Virbac Major Business
Table 40. Virbac Equine Pharmaceuticals and Supplements Product and Services
Table 41. Virbac Equine Pharmaceuticals and Supplements Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Virbac Recent Developments/Updates
Table 43. Norbrook Equine Basic Information, Manufacturing Base and Competitors
Table 44. Norbrook Equine Major Business
Table 45. Norbrook Equine Equine Pharmaceuticals and Supplements Product and Services
Table 46. Norbrook Equine Equine Pharmaceuticals and Supplements Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Norbrook Equine Recent Developments/Updates
Table 48. Kyoritsu Seiyaku Basic Information, Manufacturing Base and Competitors
Table 49. Kyoritsu Seiyaku Major Business
Table 50. Kyoritsu Seiyaku Equine Pharmaceuticals and Supplements Product and Services
Table 51. Kyoritsu Seiyaku Equine Pharmaceuticals and Supplements Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. Kyoritsu Seiyaku Recent Developments/Updates
Table 53. Vetoquinol Basic Information, Manufacturing Base and Competitors
Table 54. Vetoquinol Major Business
Table 55. Vetoquinol Equine Pharmaceuticals and Supplements Product and Services
Table 56. Vetoquinol Equine Pharmaceuticals and Supplements Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. Vetoquinol Recent Developments/Updates
Table 58. Protexin Healthcare Basic Information, Manufacturing Base and Competitors
Table 59. Protexin Healthcare Major Business
Table 60. Protexin Healthcare Equine Pharmaceuticals and Supplements Product and Services
Table 61. Protexin Healthcare Equine Pharmaceuticals and Supplements Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 62. Protexin Healthcare Recent Developments/Updates
Table 63. Audevard Basic Information, Manufacturing Base and Competitors
Table 64. Audevard Major Business
Table 65. Audevard Equine Pharmaceuticals and Supplements Product and Services
Table 66. Audevard Equine Pharmaceuticals and Supplements Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 67. Audevard Recent Developments/Updates
Table 68. Ouro Fino Saude Basic Information, Manufacturing Base and Competitors
Table 69. Ouro Fino Saude Major Business
Table 70. Ouro Fino Saude Equine Pharmaceuticals and Supplements Product and Services
Table 71. Ouro Fino Saude Equine Pharmaceuticals and Supplements Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 72. Ouro Fino Saude Recent Developments/Updates
Table 73. Global Equine Pharmaceuticals and Supplements Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 74. Global Equine Pharmaceuticals and Supplements Revenue by Manufacturer (2018-2023) & (USD Million)
Table 75. Global Equine Pharmaceuticals and Supplements Average Price by Manufacturer (2018-2023) & (USD/Unit)
Table 76. Market Position of Manufacturers in Equine Pharmaceuticals and Supplements, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 77. Head Office and Equine Pharmaceuticals and Supplements Production Site of Key Manufacturer
Table 78. Equine Pharmaceuticals and Supplements Market: Company Product Type Footprint
Table 79. Equine Pharmaceuticals and Supplements Market: Company Product Application Footprint
Table 80. Equine Pharmaceuticals and Supplements New Market Entrants and Barriers to Market Entry
Table 81. Equine Pharmaceuticals and Supplements Mergers, Acquisition, Agreements, and Collaborations
Table 82. Global Equine Pharmaceuticals and Supplements Sales Quantity by Region (2018-2023) & (K Units)
Table 83. Global Equine Pharmaceuticals and Supplements Sales Quantity by Region (2024-2029) & (K Units)
Table 84. Global Equine Pharmaceuticals and Supplements Consumption Value by Region (2018-2023) & (USD Million)
Table 85. Global Equine Pharmaceuticals and Supplements Consumption Value by Region (2024-2029) & (USD Million)
Table 86. Global Equine Pharmaceuticals and Supplements Average Price by Region (2018-2023) & (USD/Unit)
Table 87. Global Equine Pharmaceuticals and Supplements Average Price by Region (2024-2029) & (USD/Unit)
Table 88. Global Equine Pharmaceuticals and Supplements Sales Quantity by Type (2018-2023) & (K Units)
Table 89. Global Equine Pharmaceuticals and Supplements Sales Quantity by Type (2024-2029) & (K Units)
Table 90. Global Equine Pharmaceuticals and Supplements Consumption Value by Type (2018-2023) & (USD Million)
Table 91. Global Equine Pharmaceuticals and Supplements Consumption Value by Type (2024-2029) & (USD Million)
Table 92. Global Equine Pharmaceuticals and Supplements Average Price by Type (2018-2023) & (USD/Unit)
Table 93. Global Equine Pharmaceuticals and Supplements Average Price by Type (2024-2029) & (USD/Unit)
Table 94. Global Equine Pharmaceuticals and Supplements Sales Quantity by Application (2018-2023) & (K Units)
Table 95. Global Equine Pharmaceuticals and Supplements Sales Quantity by Application (2024-2029) & (K Units)
Table 96. Global Equine Pharmaceuticals and Supplements Consumption Value by Application (2018-2023) & (USD Million)
Table 97. Global Equine Pharmaceuticals and Supplements Consumption Value by Application (2024-2029) & (USD Million)
Table 98. Global Equine Pharmaceuticals and Supplements Average Price by Application (2018-2023) & (USD/Unit)
Table 99. Global Equine Pharmaceuticals and Supplements Average Price by Application (2024-2029) & (USD/Unit)
Table 100. North America Equine Pharmaceuticals and Supplements Sales Quantity by Type (2018-2023) & (K Units)
Table 101. North America Equine Pharmaceuticals and Supplements Sales Quantity by Type (2024-2029) & (K Units)
Table 102. North America Equine Pharmaceuticals and Supplements Sales Quantity by Application (2018-2023) & (K Units)
Table 103. North America Equine Pharmaceuticals and Supplements Sales Quantity by Application (2024-2029) & (K Units)
Table 104. North America Equine Pharmaceuticals and Supplements Sales Quantity by Country (2018-2023) & (K Units)
Table 105. North America Equine Pharmaceuticals and Supplements Sales Quantity by Country (2024-2029) & (K Units)
Table 106. North America Equine Pharmaceuticals and Supplements Consumption Value by Country (2018-2023) & (USD Million)
Table 107. North America Equine Pharmaceuticals and Supplements Consumption Value by Country (2024-2029) & (USD Million)
Table 108. Europe Equine Pharmaceuticals and Supplements Sales Quantity by Type (2018-2023) & (K Units)
Table 109. Europe Equine Pharmaceuticals and Supplements Sales Quantity by Type (2024-2029) & (K Units)
Table 110. Europe Equine Pharmaceuticals and Supplements Sales Quantity by Application (2018-2023) & (K Units)
Table 111. Europe Equine Pharmaceuticals and Supplements Sales Quantity by Application (2024-2029) & (K Units)
Table 112. Europe Equine Pharmaceuticals and Supplements Sales Quantity by Country (2018-2023) & (K Units)
Table 113. Europe Equine Pharmaceuticals and Supplements Sales Quantity by Country (2024-2029) & (K Units)
Table 114. Europe Equine Pharmaceuticals and Supplements Consumption Value by Country (2018-2023) & (USD Million)
Table 115. Europe Equine Pharmaceuticals and Supplements Consumption Value by Country (2024-2029) & (USD Million)
Table 116. Asia-Pacific Equine Pharmaceuticals and Supplements Sales Quantity by Type (2018-2023) & (K Units)
Table 117. Asia-Pacific Equine Pharmaceuticals and Supplements Sales Quantity by Type (2024-2029) & (K Units)
Table 118. Asia-Pacific Equine Pharmaceuticals and Supplements Sales Quantity by Application (2018-2023) & (K Units)
Table 119. Asia-Pacific Equine Pharmaceuticals and Supplements Sales Quantity by Application (2024-2029) & (K Units)
Table 120. Asia-Pacific Equine Pharmaceuticals and Supplements Sales Quantity by Region (2018-2023) & (K Units)
Table 121. Asia-Pacific Equine Pharmaceuticals and Supplements Sales Quantity by Region (2024-2029) & (K Units)
Table 122. Asia-Pacific Equine Pharmaceuticals and Supplements Consumption Value by Region (2018-2023) & (USD Million)
Table 123. Asia-Pacific Equine Pharmaceuticals and Supplements Consumption Value by Region (2024-2029) & (USD Million)
Table 124. South America Equine Pharmaceuticals and Supplements Sales Quantity by Type (2018-2023) & (K Units)
Table 125. South America Equine Pharmaceuticals and Supplements Sales Quantity by Type (2024-2029) & (K Units)
Table 126. South America Equine Pharmaceuticals and Supplements Sales Quantity by Application (2018-2023) & (K Units)
Table 127. South America Equine Pharmaceuticals and Supplements Sales Quantity by Application (2024-2029) & (K Units)
Table 128. South America Equine Pharmaceuticals and Supplements Sales Quantity by Country (2018-2023) & (K Units)
Table 129. South America Equine Pharmaceuticals and Supplements Sales Quantity by Country (2024-2029) & (K Units)
Table 130. South America Equine Pharmaceuticals and Supplements Consumption Value by Country (2018-2023) & (USD Million)
Table 131. South America Equine Pharmaceuticals and Supplements Consumption Value by Country (2024-2029) & (USD Million)
Table 132. Middle East & Africa Equine Pharmaceuticals and Supplements Sales Quantity by Type (2018-2023) & (K Units)
Table 133. Middle East & Africa Equine Pharmaceuticals and Supplements Sales Quantity by Type (2024-2029) & (K Units)
Table 134. Middle East & Africa Equine Pharmaceuticals and Supplements Sales Quantity by Application (2018-2023) & (K Units)
Table 135. Middle East & Africa Equine Pharmaceuticals and Supplements Sales Quantity by Application (2024-2029) & (K Units)
Table 136. Middle East & Africa Equine Pharmaceuticals and Supplements Sales Quantity by Region (2018-2023) & (K Units)
Table 137. Middle East & Africa Equine Pharmaceuticals and Supplements Sales Quantity by Region (2024-2029) & (K Units)
Table 138. Middle East & Africa Equine Pharmaceuticals and Supplements Consumption Value by Region (2018-2023) & (USD Million)
Table 139. Middle East & Africa Equine Pharmaceuticals and Supplements Consumption Value by Region (2024-2029) & (USD Million)
Table 140. Equine Pharmaceuticals and Supplements Raw Material
Table 141. Key Manufacturers of Equine Pharmaceuticals and Supplements Raw Materials
Table 142. Equine Pharmaceuticals and Supplements Typical Distributors
Table 143. Equine Pharmaceuticals and Supplements Typical Customers
List of Figures
Figure 1. Equine Pharmaceuticals and Supplements Picture
Figure 2. Global Equine Pharmaceuticals and Supplements Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Equine Pharmaceuticals and Supplements Consumption Value Market Share by Type in 2022
Figure 4. Pharmaceuticals Examples
Figure 5. Supplements Examples
Figure 6. Global Equine Pharmaceuticals and Supplements Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 7. Global Equine Pharmaceuticals and Supplements Consumption Value Market Share by Application in 2022
Figure 8. Thoroughbred Horse Examples
Figure 9. Other Types of Horses Examples
Figure 10. Global Equine Pharmaceuticals and Supplements Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 11. Global Equine Pharmaceuticals and Supplements Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 12. Global Equine Pharmaceuticals and Supplements Sales Quantity (2018-2029) & (K Units)
Figure 13. Global Equine Pharmaceuticals and Supplements Average Price (2018-2029) & (USD/Unit)
Figure 14. Global Equine Pharmaceuticals and Supplements Sales Quantity Market Share by Manufacturer in 2022
Figure 15. Global Equine Pharmaceuticals and Supplements Consumption Value Market Share by Manufacturer in 2022
Figure 16. Producer Shipments of Equine Pharmaceuticals and Supplements by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 17. Top 3 Equine Pharmaceuticals and Supplements Manufacturer (Consumption Value) Market Share in 2022
Figure 18. Top 6 Equine Pharmaceuticals and Supplements Manufacturer (Consumption Value) Market Share in 2022
Figure 19. Global Equine Pharmaceuticals and Supplements Sales Quantity Market Share by Region (2018-2029)
Figure 20. Global Equine Pharmaceuticals and Supplements Consumption Value Market Share by Region (2018-2029)
Figure 21. North America Equine Pharmaceuticals and Supplements Consumption Value (2018-2029) & (USD Million)
Figure 22. Europe Equine Pharmaceuticals and Supplements Consumption Value (2018-2029) & (USD Million)
Figure 23. Asia-Pacific Equine Pharmaceuticals and Supplements Consumption Value (2018-2029) & (USD Million)
Figure 24. South America Equine Pharmaceuticals and Supplements Consumption Value (2018-2029) & (USD Million)
Figure 25. Middle East & Africa Equine Pharmaceuticals and Supplements Consumption Value (2018-2029) & (USD Million)
Figure 26. Global Equine Pharmaceuticals and Supplements Sales Quantity Market Share by Type (2018-2029)
Figure 27. Global Equine Pharmaceuticals and Supplements Consumption Value Market Share by Type (2018-2029)
Figure 28. Global Equine Pharmaceuticals and Supplements Average Price by Type (2018-2029) & (USD/Unit)
Figure 29. Global Equine Pharmaceuticals and Supplements Sales Quantity Market Share by Application (2018-2029)
Figure 30. Global Equine Pharmaceuticals and Supplements Consumption Value Market Share by Application (2018-2029)
Figure 31. Global Equine Pharmaceuticals and Supplements Average Price by Application (2018-2029) & (USD/Unit)
Figure 32. North America Equine Pharmaceuticals and Supplements Sales Quantity Market Share by Type (2018-2029)
Figure 33. North America Equine Pharmaceuticals and Supplements Sales Quantity Market Share by Application (2018-2029)
Figure 34. North America Equine Pharmaceuticals and Supplements Sales Quantity Market Share by Country (2018-2029)
Figure 35. North America Equine Pharmaceuticals and Supplements Consumption Value Market Share by Country (2018-2029)
Figure 36. United States Equine Pharmaceuticals and Supplements Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 37. Canada Equine Pharmaceuticals and Supplements Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 38. Mexico Equine Pharmaceuticals and Supplements Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Europe Equine Pharmaceuticals and Supplements Sales Quantity Market Share by Type (2018-2029)
Figure 40. Europe Equine Pharmaceuticals and Supplements Sales Quantity Market Share by Application (2018-2029)
Figure 41. Europe Equine Pharmaceuticals and Supplements Sales Quantity Market Share by Country (2018-2029)
Figure 42. Europe Equine Pharmaceuticals and Supplements Consumption Value Market Share by Country (2018-2029)
Figure 43. Germany Equine Pharmaceuticals and Supplements Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 44. France Equine Pharmaceuticals and Supplements Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 45. United Kingdom Equine Pharmaceuticals and Supplements Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. Russia Equine Pharmaceuticals and Supplements Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. Italy Equine Pharmaceuticals and Supplements Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Asia-Pacific Equine Pharmaceuticals and Supplements Sales Quantity Market Share by Type (2018-2029)
Figure 49. Asia-Pacific Equine Pharmaceuticals and Supplements Sales Quantity Market Share by Application (2018-2029)
Figure 50. Asia-Pacific Equine Pharmaceuticals and Supplements Sales Quantity Market Share by Region (2018-2029)
Figure 51. Asia-Pacific Equine Pharmaceuticals and Supplements Consumption Value Market Share by Region (2018-2029)
Figure 52. China Equine Pharmaceuticals and Supplements Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 53. Japan Equine Pharmaceuticals and Supplements Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 54. Korea Equine Pharmaceuticals and Supplements Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. India Equine Pharmaceuticals and Supplements Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. Southeast Asia Equine Pharmaceuticals and Supplements Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Australia Equine Pharmaceuticals and Supplements Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. South America Equine Pharmaceuticals and Supplements Sales Quantity Market Share by Type (2018-2029)
Figure 59. South America Equine Pharmaceuticals and Supplements Sales Quantity Market Share by Application (2018-2029)
Figure 60. South America Equine Pharmaceuticals and Supplements Sales Quantity Market Share by Country (2018-2029)
Figure 61. South America Equine Pharmaceuticals and Supplements Consumption Value Market Share by Country (2018-2029)
Figure 62. Brazil Equine Pharmaceuticals and Supplements Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 63. Argentina Equine Pharmaceuticals and Supplements Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 64. Middle East & Africa Equine Pharmaceuticals and Supplements Sales Quantity Market Share by Type (2018-2029)
Figure 65. Middle East & Africa Equine Pharmaceuticals and Supplements Sales Quantity Market Share by Application (2018-2029)
Figure 66. Middle East & Africa Equine Pharmaceuticals and Supplements Sales Quantity Market Share by Region (2018-2029)
Figure 67. Middle East & Africa Equine Pharmaceuticals and Supplements Consumption Value Market Share by Region (2018-2029)
Figure 68. Turkey Equine Pharmaceuticals and Supplements Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 69. Egypt Equine Pharmaceuticals and Supplements Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 70. Saudi Arabia Equine Pharmaceuticals and Supplements Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. South Africa Equine Pharmaceuticals and Supplements Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. Equine Pharmaceuticals and Supplements Market Drivers
Figure 73. Equine Pharmaceuticals and Supplements Market Restraints
Figure 74. Equine Pharmaceuticals and Supplements Market Trends
Figure 75. Porters Five Forces Analysis
Figure 76. Manufacturing Cost Structure Analysis of Equine Pharmaceuticals and Supplements in 2022
Figure 77. Manufacturing Process Analysis of Equine Pharmaceuticals and Supplements
Figure 78. Equine Pharmaceuticals and Supplements Industrial Chain
Figure 79. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 80. Direct Channel Pros & Cons
Figure 81. Indirect Channel Pros & Cons
Figure 82. Methodology
Figure 83. Research Process and Data Source
